Shire plc : Notice of Results Shire to announ

Shire to announce third quarter 2017 results

Dublin, Ireland - October 12, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2017 earnings on Friday October 27, 2017.

Live conference call for investors: Flemming Ornskov, MD, Chief Executive Officer, Jeff Poulton, Chief Financial Officer and Matt Walker, Head of Technical Operations will host the investor and analyst conference call at 9:00 EDT / 14:00 BST.

The details of the conference call are as follows:

Replay: A replay of the presentation will be available for two weeks by phone and by webcast for three months.  Replay information can be found on the Investor Relations section of Shire's website at http://investors.shire.com/ .

For further information please contact:

NOTES TO EDITORS

About Shire

Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

www.shire.com